                               SEQUENCE LISTING

<110> DANA-FARBER CANCER INSTITUTE
 
<120> USP7 INHIBITION

<130> DFS-25325 (25992.25325)

<140> PCT/US2019/057456
<141> 2019-04-19

<150> 62/748,910
<151> 2018-10-22

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
gcttgtagat ggccatggcg                                                   20


<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
tcctcagcat cttatccgag                                                   20


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
gcagtcacag cacatgacgg                                                   20


<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
gtagtggtaa tctactggga                                                   20


